3 Reasons Pfizer Is the Best Big Pharma Stock to Buy Right Now
Past performance may not be indicative of future results. You'll find that disclaimer on mutual funds and exchange-traded funds, but it also applies to individual stocks. Pfizer (NYSE: PFE) stands out as a great example.
Over the past five years, Pfizer stock has badly underperformed the S&P 500 and many of its peers in the biopharmaceutical industry. However, you can throw that poor performance out the window now, as Pfizer is in a much better position to thrive. I think it's the best big pharma stock to buy right now. Here are three reasons why.
Image source: Getty Images.
Source Fool.com
